news
Teva announces departure of President and CEO
Dr. Jeremy Levin will step down as President and Chief…
30 October 2013 | By Teva Pharmaceutical Industries Ltd
Dr. Jeremy Levin will step down as President and Chief Executive Officer...
List view / Grid view
Jeremy Levin
news
Teva accelerates cost reduction program
$2.0 billion in annual cost savings by the end of…
10 October 2013 | By Teva Pharmaceutical Industries Ltd
$2.0 billion in annual cost savings by the end of 2017 including $1.0 billion by the end of 2014...
news
Teva Pharmaceutical announces new appointments
Dr. Carlo De Notaristefani appointed as President and CEO of…
2 August 2012 | By Teva Pharmaceutical Industries Ltd
Dr. Carlo De Notaristefani appointed as President and CEO of Global Operations, and Mr. Aharon (Arik) Yaari as the Executive VP...
news
Teva announces management succession
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb,…
1 January 2012 | By Teva
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as President and CEO...
news
Bristol-Myers Squibb to acquire Amira Pharmaceuticals
Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule…
21 July 2011 | By Bristol-Myers Squibb
Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company...
